Fact CheckerSign in

NCT06329245Recruiting

Development of Prosocial Behaviors and Related Brain Network in Infants of High and Low Risk of ASD

Source: ClinicalTrials.gov · Last updated 16 Mar 2026

Brief summary (registry, in English)

The goal of this observational study is to compare the developmental trajectories of prosocial behaviors and functional network connections in infants and toddlers at high and low risk of autism spectrum disorder (ASD). The main questions it aims to answer are what the differences in prosocial behaviors and related brain network connections between infants/toddlers at high and low risk of ASD are. Participants will receive developmental and social communicational assessments (Griffiths Mental Developmental Scales, Peabody Developmental Motor Scales, The Communication and Symbolic Behavior Scales Developmental Profile Infant-Toddler Checklist), resting-state EEG and MRI in a natural sleeping state.

Status (registry)
Recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
19 Mar 2024
Start date
Apr 2024
Primary completion date
Jan 2029
Lead sponsor
Children's Hospital of Fudan University
Diseases
Autism
NCT number
NCT06329245

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From Apr 2024 to the primary completion date, Jan 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • possible perinatal brain injury from exposure to in-utero exogenous compounds reported to likely affect the brain adversely in at least some individuals (e.g., alcohol, selected prescription medications);
  • contraindication for MRI (e.g., metal implants);

Other illness

  • diagnosis or physical signs strongly suggestive of a genetic condition or syndrome (e.g., fragile X syndrome) reported to be associated with ASDs;
  • a significant medical or neurological condition affecting growth, development or cognition (e.g., CNS infection, seizure disorder, congenital heart disease);
  • sensory impairment such as vision or hearing loss;
  • a family history of intellectual disability, psychosis, schizophrenia or bipolar disorder in a first-degree relative.

Other

  • low birth weight (\<2000 grams) or prematurity (\<37 weeks gestation);

Who the study is looking for

  • Subjects were enrolled as high-risk if they had an older sibling with a clinical diagnosis of ASD confirmed on the Autism Diagnostic Observation Schedule, second edition (ADOS-2) or Autism Diagnostic Interview (ADI-R).
  • Subjects were enrolled in the low-risk group if they had an older sibling without evidence of ASD and no family history of a first or second-degree relative with ASD.

Age in the registry: 0 months to 18 months · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Children's Hospital Of Fudan University
Coordinator of this site? Confirm its status
ShanghaiChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.